These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7082835)

  • 1. Decreased number of circulating BFU-Es in paroxysmal nocturnal hemoglobinuria.
    Rotoli B; Robledo R; Luzzatto L
    Blood; 1982 Jul; 60(1):157-9. PubMed ID: 7082835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decay-accelerating factor is present on paroxysmal nocturnal hemoglobinuria erythroid progenitors and lost during erythropoiesis in vitro.
    Moore JG; Frank MM; Müller-Eberhard HJ; Young NS
    J Exp Med; 1985 Oct; 162(4):1182-92. PubMed ID: 2413153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth of mixed erythroid-granulocytic colonies in culture derived from bone marrow of patients with paroxysmal nocturnal hemoglobinuria without addition of exogenous stimulator.
    Issaragrisil S; Piankijagum A; Chinprasertsuk S; Kruatrachue M
    Exp Hematol; 1986 Oct; 14(9):861-6. PubMed ID: 3758236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the hematopoietic defect in paroxysmal nocturnal hemoglobinuria.
    Moore JG; Humphries RK; Frank MM; Young N
    Exp Hematol; 1986 Mar; 14(3):222-9. PubMed ID: 3512279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical paroxysmal nocturnal hemoglobinuria is the result of expansion of glycosyl-phosphatidyl-inositol-anchored protein-deficient clone in the condition of deficient hematopoiesis.
    Pakdeesuwan K; Muangsup W; Pratya YU; Issaragrisil S; Wanachiwanawin W
    Int J Hematol; 2001 Jan; 73(1):64-70. PubMed ID: 11372757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of paroxysmal nocturnal hemoglobinuria clonal dominance: possible roles of different apoptosis and CD8+ lymphocytes in the selection of paroxysmal nocturnal hemoglobinuria clones.
    Kunyaboon R; Wanachiwanawin W; U-Pratya Y; Thedsawad A; Taka O
    Hematol Oncol Stem Cell Ther; 2012; 5(3):138-45. PubMed ID: 23095789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement sensitivity of erythroblasts and erythropoietic precursors in paroxysmal nocturnal haemoglobinuria (PNH).
    Shichishima T; Terasawa T; Uchida T; Kariyone S
    Br J Haematol; 1989 Aug; 72(4):578-83. PubMed ID: 2775661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reticulocyte-gated flow cytometric analysis of red blood cells in paroxysmal nocturnal hemoglobinuria.
    Sato S; Hasegawa Y; Nagasawa T; Ninomiya H
    Lab Hematol; 2006; 12(2):82-5. PubMed ID: 16751135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two populations of erythroid cell progenitors in paroxysmal nocturnal hemoglobinuria.
    Rotoli B; Robledo R; Scarpato N; Luzzatto L
    Blood; 1984 Oct; 64(4):847-51. PubMed ID: 6478058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of decay-accelerating factor on hematopoietic progenitors and their progeny cells grown in cultures with fractionated bone marrow cells from normal individuals and patients with paroxysmal nocturnal hemoglobinuria.
    Okuda K; Kanamaru A; Ueda E; Kitani T; Okada N; Okada H; Kakishita E; Nagai K
    Exp Hematol; 1990 Nov; 18(10):1132-6. PubMed ID: 1698649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro proliferation and differentiation of megakaryocytic progenitors in patients with aplastic anemia, paroxysmal nocturnal hemoglobinuria, and the myelodysplastic syndromes.
    Cox CV; Killick SB; Patel S; Elebute MO; Marsh JC; Gordon-Smith EC; Gibson FM
    Stem Cells; 2000; 18(6):428-34. PubMed ID: 11072031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferative capacity of single isolated CD34+ hematopoietic stem/progenitor cells in paroxysmal nocturnal hemoglobinuria.
    Han B; Wu Y; Lu Z; Zhang Z
    Int J Hematol; 2001 Jul; 74(1):42-52. PubMed ID: 11530804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythroid progenitors in paroxysmal nocturnal haemoglobinuria.
    Urabe A; Fujioka S
    Br J Haematol; 1982 Feb; 50(2):295-8. PubMed ID: 7059520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating primitive stem cells in paroxysmal nocturnal hemoglobinuria (PNH) are predominantly normal in phenotype but granulocyte colony-stimulating factor treatment mobilizes mainly PNH stem cells.
    Johnson RJ; Rawstron AC; Richards S; Morgan GJ; Norfolk DR; Hillmen SO
    Blood; 1998 Jun; 91(12):4504-8. PubMed ID: 9616145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement sensitivity of erythroid and myeloid precursors in paroxysmal in nocturnal hemoglobinuria.
    Ishida Y; Matsumoto N; Shinohara K; Yamada K; Inoue M; Kaneko T; Murphy MJ
    Int J Cell Cloning; 1984 Sep; 2(5):316-26. PubMed ID: 6491393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paroxysmal nocturnal hemoglobinuria: molecular pathogenesis and molecular therapeutic approaches.
    Nishimura J; Smith CA; Phillips KL; Ware RE; Rosse WF
    Hematopathol Mol Hematol; 1998; 11(3-4):119-46. PubMed ID: 9844822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of GPI-anchor proteins during the differentiation from hematopoietic progenitors in patients with paroxysmal nocturnal hemoglobinuria].
    Kanamaru A; Nishimura T
    Rinsho Ketsueki; 1994 Apr; 35(4):358-63. PubMed ID: 8028180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of T-lymphocytes on hematopoietic progenitors in patients with paroxysmal nocturnal hemoglobinuria].
    Gao Q; Xia H; Chen Y
    Zhonghua Xue Ye Xue Za Zhi; 1998 Oct; 19(10):522-4. PubMed ID: 11189496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased resistance of PIG-A- bone marrow progenitors to tumor necrosis factor a and interferon gamma: possible implications for the in vivo dominance of paroxysmal nocturnal hemoglobinuria clones.
    Barcellini W; Fermo E; Guia Imperiali F; Zaninoni A; Bianchi P; Boschetti C; Zanella A
    Haematologica; 2004 Jun; 89(6):651-6. PubMed ID: 15194531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycling stress in the monocyte line as a risk factor for progression of the aplastic anaemia/paroxysmal nocturnal haemoglobinuria syndrome to myelodysplastic syndrome.
    Nissen C; Genitsch A; Sendelov S; Dalle Carbonare V; Wodnar-Filipowicz A
    Acta Haematol; 2000; 103(1):33-40. PubMed ID: 10705157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.